Polymeric nanosystems for cardiovascular therapeutics
Polymeric Nanosystems, Page: 699-722
2023
- 6Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures6
- Readers6
Book Chapter Description
Cardiovascular disorders are the leading risk factor and a common cause of death in a substantial proportion of the world’s population. The incidence of cardiovascular disease is growing due to a rise in diets high in saturated fat, salt, and sugar. It also occurs in people who live sedentary lifestyles and have obesity. Currently, the only choices for treating cardiovascular conditions are oral medications or invasive surgery. There is a tremendous need for new therapeutics in this field of medicine to enhance clinical care. Nanotechnology could make a major contribution to more successful disease treatment, better early diagnosis, and a lower risk of side effects. A wide range of theranostic nanosystems has been developed over the last few decades. The flexibility, adaptability, and biocompatibility of adequately formulated composites have been used to make remarkable development in drug delivery using polymeric theranostic nanosystems.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/B9780323856560000140; http://dx.doi.org/10.1016/b978-0-323-85656-0.00014-0; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85160146138&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/B9780323856560000140; https://dx.doi.org/10.1016/b978-0-323-85656-0.00014-0
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know